2018 Stanford Drug Discovery Conference

Using the Innovation Ecosystem to Build a Robust Pipeline

Preview Available

Using the Innovation Ecosystem to Build a Robust Pipeline

• Brent Saunders, MBA, JD, Allergan

Treating Disease by Manipulating the Immune System

Preview Available

Treating Disease by Manipulating the Immune System

• Edgar Engleman, MD, Stanford University School of Medicine

Fireside Chat with Marc Tessier-Lavigne

Preview Available

Fireside Chat with Marc Tessier-Lavigne

• Marc Tessier-Lavigne, PhD, Stanford University

Charting our Future Together: Advancing Discovery Science for Public Health impact

Preview Available

Charting our Future Together: Advancing Discovery Science for Public Health impact

• Gary Gibbons, MD, National Heart, Lung, and Blood Institute

Transitioning from Big Pharma to Startup

Preview Available

Transitioning from Big Pharma to Startup

• George Scangos, PhD, Vir

Intelligent Intervention: Ozanimod from hit to NCE at Scripps

Preview Available

Intelligent Intervention: Ozanimod from hit to NCE at Scripps

• Hugh Rosen, MD, PhD, Scripps Research Institute

Transparency and Reproducibility in Science: How Journals Can Help

Preview Available

Transparency and Reproducibility in Science: How Journals Can Help

• Joao Monteiro, MD, PhD, Nature Medicine

Outcomes Based Pricing

Preview Available

Outcomes Based Pricing

• Joe Jimenez, MBA

Regulatory Science in Academia: Advancing Drug Development

Preview Available

Regulatory Science in Academia: Advancing Drug Development

• Kathleen Giacomini, PhD, UCSF School of Medicine

Inventing for Life: the CEO Perspective

Preview Available

Inventing for Life: the CEO Perspective

• Ken Frazier, JD, Merch & Co., Inc.